Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 19. November 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9155  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 183084  
   
French AFU Cancer Committee Guidelines - Update 2026-2028: Testicular germ cell cancer.
Fr J Urol
Murez T, Fléchon A, Branger N, Savoie PH, Rocher L, Camparo P, Neuville P, Escoffier A, Levy S, Goujon A, Roupret M.
PMID: 43051711 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Upper urinary tract urothelial tumors (UTUC).
Fr J Urol
Roumiguié M, Leon P, Xylinas E, Thibault C, Seisen T, Prost D, Allory Y, Bajeot AS, Pradère B, Neuzillet Y, Marcq G, Audenet F, Borchiellini D, Gabriel PE, Masson-Lecomte A, Roupret M.
PMID: 43051710 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Muscle-invasive bladder tumors (MIBC).
Fr J Urol
Roumiguié M, Marcq G, Bajeot AS, Allory Y, Borchiellini D, Sargos P, Leon P, Masson-Lecomte A, Neuzillet Y, Audenet F, Gabriel PE, Xylinas E, Pradère B, Prost D, Thibault C, Seisen T, Roupret M.
PMID: 43051709 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Prostate cancer - Diagnosis and management of localized disease.
Fr J Urol
Ploussard G, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Olivier J, Dariane C, Mathieu R, Rozet F, Peyrottes A, Roubaud G, Renard-Penna R, Sargos P, Supiot S, Turpin L, Rouprêt M.
PMID: 43051708 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Non-muscle-invasive bladder tumors (NMIBC).
Fr J Urol
Roumiguié M, Pradère B, Bajeot AS, Leon P, Xylinas E, Allory Y, Marcq G, Prost D, Neuzillet Y, Thibault C, Gabriel PE, Borchiellini D, Masson-Lecomte A, Seisen T, Audenet F, Roupret M.
PMID: 43051707 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Kidney cancer.
Fr J Urol
Bigot P, Khene ZE, Margue G, Albiges L, Barthelemy P, Bernhard JC, Correas JM, De Vergie S, Doumerc N, Ferragu M, Ingels A, Ouzaïd I, Pettenati C, Rioux-Leclercq N, Chapet O, Waeckel T, Boissier R, Rourpret M.
PMID: 43051705 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Prostate Cancer - Treatment of relapse and metastatic disease.
Fr J Urol
Ploussard G, Dariane C, Mathieu R, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Olivier J, Rozet F, Peyrottes A, Renard-Penna R, Sargos P, Supiot S, Turpin L, Roubaud G, Rouprêt M, Cancer Committee of the French Association of Urology.
PMID: 43051704 [PubMed - indexed for MEDLINE]


Single- Versus Two-Fraction HDR Brachytherapy Boost for Prostate Cancer: Long-Term Oncologic and Toxicity Outcomes.
Pract Radiat Oncol
Goñi A, Sevilla M, Larruskain M, Eguiguren M, Perez A, de Urturi ES, Iceta U, Roura DA, Alberich M, Minguez J, Urraca JM, Querejeta A.
PMID: 43051583 [PubMed - as supplied by publisher]


Homologous recombination repair gene alterations in prostate cancer: expert recommendations for genetic and biomarker testing.
Curr Opin Urol
Shariat SF, Morgan TM, Wyatt AW, Mehra N, Lang J, Briers E, Liang S, Grimm MO.
PMID: 43050498 [PubMed - as supplied by publisher]


Radiopharmaceutical therapy for metastatic prostate cancer: Insights from mechanistic modeling and in silico trials.
PLoS Comput Biol
Italia M, Bordel-Vozmediano S, García Otero J, Calvo GF, Pérez-García VM.
PMID: 43050486 [PubMed - as supplied by publisher]


Peritumoral CT Features Improve the Prediction of Nuclear Grade in Small (2-4 cm) Solid Clear Cell Renal Cell Carcinoma: A Multicenter Study.
Ann Surg Oncol
Song X, Li X, Sun F, Wang Y, Sun D, Zhang W, Zheng Z, Zhang S, Li W, Qu J.
PMID: 43050123 [PubMed - as supplied by publisher]


Divorce and suicide mortality after prostate cancer diagnosis: a population-based competing-risks analysis.
J Cancer Surviv
Linares-Perdomo O, Klebe D, Swami U, Odei BC.
PMID: 43050028 [PubMed - as supplied by publisher]


Illuminating the future: energy-based focal therapies for prostate cancer.
Clin Transl Oncol
Mukherjee AG, Gopalakrishnan AV.
PMID: 43050020 [PubMed - as supplied by publisher]


Impact of diagnostic transurethral bladder tumour resection on the release of circulating tumour cells.
Bladder Cancer
Verhaegh GW, Kiemeney LA, van Hoogstraten LMC, Groen L, de Vocht TF, Dijkstra S, van den Wildenberg AM, van der Heijden AG.
PMID: 43048459 [PubMed]


Effects of cabozantinib monotherapy starting dose on treatment outcomes in metastatic renal cell carcinoma: A real-world cohort study from Southwest Finland.
Ther Adv Urol
Kosola S, Ahtiainen L, Miedema J, Mårdby AC, Rockberg J, Perrot V, Kauko T, Tapana L, Mattila KE.
PMID: 43048443 [PubMed]


Exosomal and extracellular-vesicle miRNAs in prostate cancer-bone communication: mechanisms, biomarkers, and translational challenges.
Front Cell Dev Biol
Shen Y, Ju B.
PMID: 43048074 [PubMed]


PD-1/PD-L1 inhibitor-based regimens in sarcomatoid renal cell carcinoma: a meta-analysis of randomized controlled trials and single-arm studies.
Front Immunol
Zheng K, Zhang L, Huang Z, Ye B, Ren P, Zhang Q.
PMID: 43047712 [PubMed - indexed for MEDLINE]


Unveiling the missing link between chronic prostatitis and prostate cancer: emerging roles of exosomal miRNAs as extracellular vesicle messengers.
Front Immunol
Shen Y, Ju B.
PMID: 43047308 [PubMed - indexed for MEDLINE]


Hydrogel-Based Therapies for Bladder Cancer: Intravesical Delivery, Immunomodulation, and Precision.
Tissue Eng Part B Rev
Han J, Li X, Zhou X, Zhang Y.
PMID: 43046810 [PubMed - as supplied by publisher]


A Self-Confined Rotational Hydrogel Chemiluminescence Motor Array for Rapid and Sensitive Detection of Bladder Cancer Biomarkers.
Anal Chem
Wang W, Xing Z, Wang B, Zheng S, Zeng L, Wang J.
PMID: 43046401 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 183084    Seite 1 von 9155  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1